concentra, pharma, pricing, market access, data, visualisation

Download: Top 5 Pricing and Market Access Visualisations every pharmaceutical organisation needs

Analytics is a hot topic in pharmaceuticals and life sciences. Data visualisation is unlocking new understanding and value at all stages of the product lifecycle. Once the territory of the research and development process, big data analytics is now becoming the differentiator in commercial and operational decision making. How can you get the most out of your pricing and market …

Hikma, Pharma, Generics

Review of market dynamics in MENA: What are the market drivers, opportunities and challenges?

At the World Generic Medicines Congress Europe 2014, Salah Mawajdeh, Hikma Pharmaceuticals, gave a presentation on “Review of market dynamics in MENA: What are the market drivers, opportunities and challenges?”  The presentation focuses on healthcare and growth within the MENA region. Download and learn: The pharmaceutical industry in MENA High barriers to entry in the MENA & Hikma’s differentiated market position …

IP, Pharma, Generics, Opportunities, Challenges, Europe,

IP in Pharma Generics Opportunities & Challenges in the EU

At the World Generic Medicines Congress Europe 2014, Thomas Kolzau, Helm AG, gave a presentation entitled “IP in Pharma Generics Opportunities & Challenges in the EU” Download and learn: Opportunities – pharma generics Challenges – pharma generics Oppositions in the generic market Appeals in the generic market Settlement Manufacturing & stockpiling Importance of the EU generics industry Impact of a manufacturing …

pharma, pharma pricing, market access, drug, considerations, pharma pricing and market access europe

Ebook: Key Considerations for Market Access

In an era of austerity and rising health care costs, payers are exerting greater influence over pharmaceutical markets and demanding insight into a drug’s value and cost effectiveness. Creating an effective market access strategy is vital for a successful product launch. You need to integrate the payer perspective throughout the development and decisions making process. In this ebook, we share …

Netherlands, Anticipate, Future, Pharma, Pharma Pricing

The Netherlands: How to anticipate future pharma and healthcare dynamics?

At the World Pharma Pricing and Market Access Congress 2014, Cornelis Boersma, Head Market Access GSK, gave a presentation “The Netherlands: How to anticipate future pharma and healthcare dynamics?” Boersma’s presentation reflects his attitude “Change towards a predictable and sustainable decision-making system!” Download and learn: Trends in healthcare and pharma expenditures Dutch Pharma system under development NL policy: Implementation of ‘Vuvuzela’ Market Access and …

Increase in Continuous Processing and Single-Use in Future Biomanufacture Forecast in New Review

A review by Institute for Separation and Process Technology has predicted an increase in the use of single use technologies and continuous processing within the manufacture of biologics in the future. Researchers Jochen Strube, Reinhard Ditz and Petra Gronemeyer, predict that demands for high quality biologics will continue to increase in the coming decades. Decreasing production and imminent patent expirations of ‘blockbuster’ drugs coupled with a …

crm, marketing, life sciences, pharma, sales, strategy, speciality

Download: 10 Reasons Why “CRM-in-a-Box” Doesn’t Work for Specialty Life Sciences

  Specialty drug or device selling is as different from the traditional primary care business model as podiatrists are from pediatricians. Today’s industry is moving away from armies of sales representatives to smaller, more focused specialty sales teams. The entire selling process (indeed, the entire industry) is under pressure to perform more efficiently with fewer resources, to find and implement better tools and …

Download: A Pharma Prospective On CER And How It Can Aid Payer Coverage Policies

At Market Access USA 2013, Keith Huff, PharmD, MS gave a presentation on “A Pharma Prospective On Comparative Effectiveness Research And How It Can Aid Payer Coverage Policies” Download the presentation to learn: Needs of the Payer Needs of Pharma Comparative Effectiveness Research How is CER used Needs for credible CER studies Challenges in CER Research Comparing types of data …

pharmaceuticalethics, pharma, compliance, clinical, app, health, digipharm, pharma engagement live

Clinical, moral and compliance dilemmas in health app development

Nick Broughton, Managing Director of Pharmaceuticalethics.com gives his presentation on ‘Clinical, moral and compliance dilemmas in health app development’ at DigiPharm 2013.  Watch the full video. Interested in learning more?  Join us at Pharma Engagement Live 2014, held this 7-8 October in London at the Business Design Centre.  Explore the issues involved in engaging, supporting and educating both patients, carers and …